Halyard Health (NYSE: HYH) is one of 81 publicly-traded companies in the “Medical Equipment, Supplies & Distribution” industry, but how does it weigh in compared to its peers? We will compare Halyard Health to related businesses based on the strength of its institutional ownership, profitability, dividends, earnings, valuation, risk and analyst recommendations.
Earnings & Valuation
This table compares Halyard Health and its peers gross revenue, earnings per share and valuation.
|Gross Revenue||Net Income||Price/Earnings Ratio|
|Halyard Health||$1.59 billion||$39.80 million||39.84|
|Halyard Health Competitors||$975.11 million||$120.37 million||222.21|
Risk and Volatility
Halyard Health has a beta of 1.77, indicating that its stock price is 77% more volatile than the S&P 500. Comparatively, Halyard Health’s peers have a beta of 0.93, indicating that their average stock price is 7% less volatile than the S&P 500.
This is a summary of current ratings and recommmendations for Halyard Health and its peers, as provided by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Halyard Health Competitors||211||1261||2730||95||2.63|
Halyard Health presently has a consensus target price of $44.00, indicating a potential downside of 7.19%. As a group, “Medical Equipment, Supplies & Distribution” companies have a potential upside of 7.20%. Given Halyard Health’s peers stronger consensus rating and higher possible upside, analysts plainly believe Halyard Health has less favorable growth aspects than its peers.
Insider & Institutional Ownership
90.3% of Halyard Health shares are owned by institutional investors. Comparatively, 65.6% of shares of all “Medical Equipment, Supplies & Distribution” companies are owned by institutional investors. 1.3% of Halyard Health shares are owned by insiders. Comparatively, 12.0% of shares of all “Medical Equipment, Supplies & Distribution” companies are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
This table compares Halyard Health and its peers’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Halyard Health Competitors||-421.16%||-42.63%||-12.34%|
Halyard Health peers beat Halyard Health on 7 of the 13 factors compared.
About Halyard Health
Halyard Health, Inc. is a medical technology company. The Company operates through two segments: Medical Devices and Surgical and Infection Prevention (S&IP). The Medical Devices segment provides a portfolio of product offerings focused on pain management, respiratory and digestive health. The S&IP segment provides healthcare supplies and solutions that target the prevention of healthcare-associated infections. The Company address healthcare needs, such as reducing the use of opioids, while helping patients move from surgery to recovery. The Medical Devices segment’s products include post-operative pain management solutions, minimally invasive interventional (or chronic) pain therapies, closed airway suction systems and enteral feeding tubes. The S&IP segment includes product offerings, such as sterilization wrap, surgical drapes and gowns, facial protection, protective apparel and medical exam gloves.
What are top analysts saying about Halyard Health Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Halyard Health Inc. and related companies.